Patents by Inventor Paul T. Smith, JR.

Paul T. Smith, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triazolopyridine compounds and methods for the treatment of cystic fibrosis
    Patent number: 10472357
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: November 12, 2019
    Assignee: Flatley Discovery Lab, LLC
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, Jr.
  • Triazolopyridine Compounds and Methods for the Treatment of Cystic Fibrosis
    Publication number: 20180230146
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: February 8, 2018
    Publication date: August 16, 2018
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, JR.
  • Triazolopyridine compounds and methods for the treatment of cystic fibrosis
    Patent number: 9926315
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Grant
    Filed: January 19, 2017
    Date of Patent: March 27, 2018
    Assignee: Flatley Discovery Lab, LLC
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, Jr.
  • TRIAZOLOPYRIDINE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20170233388
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: January 19, 2017
    Publication date: August 17, 2017
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, JR.
  • Triazolopyridine compounds and methods for the treatment of cystic fibrosis
    Patent number: 9573948
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: February 21, 2017
    Assignee: Flatley Discovery Lab
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, Jr.
  • TRIAZOLOPYRIDINE COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20160096835
    Abstract: The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:
    Type: Application
    Filed: October 6, 2015
    Publication date: April 7, 2016
    Inventors: Bridget M. Cole, Richard A. Nugent, Paul T. Smith, JR.